Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of salmeterol and fluticasone on alveolar nitric oxide in stable bronchiectasis
2007-000936-21Phase 3Terminated
- Sponsor
- Royal Brompton Hospital
- Start
- Mar 2007
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of salmeterol and fluticasone in bronchiectasis (3 arms), sponsored by Royal Brompton Hospital. Primary endpoint: Change in alveolar nitric oxide levels. Started Mar 2007; status: terminated.
02
Drugs
salmeterolfluticasone
03
Conditions
bronchiectasis
Beyond the preview
Go deeper on 2007-000936-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-000936-21.